Publications
- Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection2022 | Faculty of Medicine in Pilsen
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors2020 | Faculty of Medicine in Pilsen
- Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer2020 | Faculty of Medicine in Pilsen
- Octreotide in the treatment of malignant thymoma - Case report2020 | Faculty of Medicine in Pilsen
- Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine
Loading network view...
